Sentry Investment Management LLC Purchases 117 Shares of Perrigo Company (PRGO)
Sentry Investment Management LLC grew its position in shares of Perrigo Company (NYSE:PRGO) by 1.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 11,028 shares of the company’s stock after purchasing an additional 117 shares during the quarter. Sentry Investment Management LLC’s holdings in Perrigo were worth $833,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in the company. Korea Investment CORP lifted its stake in shares of Perrigo by 142.0% in the second quarter. Korea Investment CORP now owns 1,331 shares of the company’s stock worth $101,000 after acquiring an additional 781 shares during the period. Commonwealth Bank of Australia lifted its stake in shares of Perrigo by 13.8% in the second quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock worth $108,000 after acquiring an additional 176 shares during the period. Global X Management Co. LLC lifted its stake in shares of Perrigo by 56.4% in the first quarter. Global X Management Co. LLC now owns 2,370 shares of the company’s stock worth $157,000 after acquiring an additional 855 shares during the period. Bessemer Group Inc. lifted its stake in shares of Perrigo by 1,046.2% in the second quarter. Bessemer Group Inc. now owns 2,235 shares of the company’s stock worth $169,000 after acquiring an additional 2,040 shares during the period. Finally, Bank of Nova Scotia lifted its stake in shares of Perrigo by 2.5% in the first quarter. Bank of Nova Scotia now owns 3,219 shares of the company’s stock worth $214,000 after acquiring an additional 80 shares during the period. 82.44% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently commented on the company. Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the stock a “buy” rating in a research note on Friday. UBS AG reiterated a “buy” rating and issued a $98.00 target price (up from $84.00) on shares of Perrigo in a report on Thursday, October 5th. Oppenheimer Holdings, Inc. started coverage on Perrigo in a report on Monday, October 2nd. They issued a “buy” rating and a $88.00 target price for the company. BidaskClub upgraded Perrigo from a “sell” rating to a “hold” rating in a report on Saturday, September 16th. Finally, Deutsche Bank AG lifted their target price on Perrigo from $88.00 to $95.00 and gave the stock a “buy” rating in a report on Thursday, September 14th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $88.50.
In related news, EVP Jeffrey Needham sold 3,595 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The stock was sold at an average price of $89.49, for a total transaction of $321,716.55. Following the completion of the transaction, the executive vice president now owns 10,118 shares of the company’s stock, valued at approximately $905,459.82. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Sharon Kochan sold 318 shares of the firm’s stock in a transaction that occurred on Thursday, September 7th. The shares were sold at an average price of $81.36, for a total value of $25,872.48. Following the transaction, the executive vice president now directly owns 10,231 shares of the company’s stock, valued at approximately $832,394.16. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,894 shares of company stock valued at $581,320. 6.90% of the stock is currently owned by company insiders.
Shares of Perrigo Company (NYSE:PRGO) opened at 87.44 on Friday. The company’s market cap is $12.47 billion. Perrigo Company has a 12-month low of $63.68 and a 12-month high of $91.95. The stock’s 50 day moving average price is $85.70 and its 200 day moving average price is $76.16.
Perrigo (NYSE:PRGO) last released its earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.28. The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.18 billion. Perrigo had a positive return on equity of 11.55% and a negative net margin of 51.04%. The firm’s revenue for the quarter was down 7.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.93 EPS. On average, analysts forecast that Perrigo Company will post $4.59 EPS for the current year.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Stock Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related stocks with our FREE daily email newsletter.